Biosensors and Molecular Technologies for Cancer Diagnostics
116,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

Bridging the gap between research and clinical application, this volume explores the use of biosensors as effective alternatives to the current standard methods in cancer diagnosis and detection. It describes the major aspects involved in detecting and diagnosing cancer as well as the basic elements of biosensors and their applications in detection and diagnostics. Making biosensor technology more accessible to molecular biologists, oncologists, pathologists, and engineers, the book advances the integration of this technology into mainstream clinical practice.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Bridging the gap between research and clinical application, this volume explores the use of biosensors as effective alternatives to the current standard methods in cancer diagnosis and detection. It describes the major aspects involved in detecting and diagnosing cancer as well as the basic elements of biosensors and their applications in detection and diagnostics. Making biosensor technology more accessible to molecular biologists, oncologists, pathologists, and engineers, the book advances the integration of this technology into mainstream clinical practice.
Autorenporträt
Keith E. Herold is an associate professor in the Fischell Department of Bioengineering at the University of Maryland. A fellow of the ASME, Dr. Herold has over 10 years of experience in the analysis and testing of biosensor systems. His current research interests include bioMEMS, microfluidic systems for bioanalytical assays, and heat and mass transfer in bioengineering. Avraham Rasooly is the chief of the Disparities Research Branch at the National Cancer Institute and a member of the Division of Biology in the Center for Devices and Radiological Health at the U.S. Food and Drug Administration.